Evidence map›Paper›PMID 35196829›Full record

ArticlePsychiatry investigation2022

Development of the Korea-Polyenvironmental Risk Score for Psychosis.

Eun-Jin Jeon, Shi-Hyun Kang, Yan-Hong Piao, Sung-Wan Kim, Jung-Jin Kim, Bong-Ju Lee, Je-Chun Yu, Kyu-Young Lee, Seung-Hee Won, Seung-Hwan Lee and 7 more

Abstract read
In one paragraph

Article in Psychiatry investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Eun-Jin JeonDepartment of Psychiatry, Jeonbuk National University Hospital, Jeonju, Republic of Korea.
Shi-Hyun KangDepartment of Social Psychiatry and Rehabilitation, National Center for Mental Health, Seoul, Republic of Korea.
Yan-Hong PiaoDepartment of Psychiatry, Jeonbuk National University Medical School, Jeonju, Republic of Korea.
Sung-Wan KimDepartment of Psychiatry, Chonnam National University Medical School, Gwangju, Republic of Korea.
Jung-Jin KimDepartment of Psychiatry, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Republic of Korea.
Bong-Ju LeeDepartment of Psychiatry, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea.
Je-Chun YuDepartment of Psychiatry, Eulji University School of Medicine, Eulji University Hospital, Daejeon, Republic of Korea.
Kyu-Young LeeDepartment of Psychiatry, Nowon Eulji Medical Center, Eulji University, Seoul, Republic of Korea.
Seung-Hee WonDepartment of Psychiatry, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Seung-Hwan LeeDepartment of Psychiatry, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea.
Seung-Hyun KimDepartment of Psychiatry, Korea University College of Medicine, Guro Hospital, Seoul, Republic of Korea.
Eui-Tae KimDepartment of Psychiatry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Clara Tammy KimInstitute of Life and Death Studies, Hallym University, Chuncheon, Republic of Korea.
Dominic OliverEarly Psychosis: Interventions and Clinical Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Paolo Fusar-PoliEarly Psychosis: Interventions and Clinical Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Fatima Zahra RamiDepartment of Psychiatry, Jeonbuk National University Medical School, Jeonju, Republic of Korea.
Young-Chul ChungDepartment of Psychiatry, Jeonbuk National University Hospital, Jeonju, Republic of Korea.

Funding

Korea Health Industry Development InstituteMinistry of Health and Welfare HI18C2383Ministry of Health and Welfare HL19C0015
6 · The paper itself

Abstract

objectiveComprehensive understanding of polyenvironmental risk factors for the development of psychosis is important. Based on a review of related evidence, we developed the Korea Polyenvironmental Risk Score (K-PERS) for psychosis. We investigated whether the K-PERS can differentiate patients with schizophrenia spectrum disorders (SSDs) from healthy controls (HCs).

methodsWe reviewed existing tools for measuring polyenvironmental risk factors for psychosis, including the Maudsley Environmental Risk Score (ERS), polyenviromic risk score (PERS), and Psychosis Polyrisk Score (PPS). Using odds ratios and relative risks for Western studies and the "population proportion" (PP) of risk factors for Korean data, we developed the K-PERS, and compared the scores thereon between patients with SSDs and HCs. In addition, correlation was performed between the K-PERS and Positive and Negative Syndrome Scale (PANSS).

resultsWe first constructed the "K-PERS-I," comprising five factors based on the PPS, and then the "K-PERS-II" comprising six factors based on the ERS. The instruments accurately predicted participants' status (case vs. control). In addition, the K-PERS-I and -II scores exhibited significant negative correlations with the negative symptom factor score of the PANSS.

conclusionThe K-PERS is the first comprehensive tool developed based on PP data obtained from Korean studies that measures polyenvironmental risk factors for psychosis. Using pilot data, the K-PERS predicted patient status (SSD vs. HC). Further research is warranted to examine the relationship of K-PERS scores with clinical outcomes of psychosis and schizophrenia.

Indexed as

Polyenvironmental risk factorPredictionPsychosis

Identifiers

PMID35196829
PMCPMC8958209

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.